Back to Trades
Delaet Ingrid
Chief Regulatory OfficerCIK 0001965808
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 6
- Companies
- 1
- Active
- 2025–2026
Across 7 filings between 2025–2026, Delaet Ingrid, Chief Regulatory Officer, has disclosed $14.1M in transactions — all concentrated in NEUROCRINE BIOSCIENCES INC (NBIX). Their disclosed trades are heavily weighted toward selling — $0 in buys and $3.8M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Sep 15 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Grant | $377.9K |
| Jul 13 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Sell | $790.5K |
| Jul 9 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Sell | $2.6M |
| Jun 2 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Sell | $354.3K |
| Feb 17 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Grant | $5.5M |
| Feb 3 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Exercise | $64.6K |
| Jul 11 | NBIX NEUROCRINE BIOSCIENCES INC | Delaet Ingrid | Chief Regulatory Officer | Sell | $61.7K |
7 filings